A Phase 1 Study Of Rad1901, A Novel, Orally Available, Selective Estrogen Receptor Degrader, For The Treatment Of Er Positive Advanced Breast CancerWael A. Harb,Fiona Garner, J McDermott, T Zimmerman,G Williams,Gary Hattersley,D PurandareCANCER RESEARCH（2016）引用 1|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
